The odds of Staples gaining regulatory clearance for its $6.3 billion purchase of rival Office Depot have improved greatly, according to a confidential report on Monday.
The Federal Trade Commission met last Friday with a large corporate customer of Staples to discuss an antitrust remedy to get the deal done, according to the report issued by Bank of America, a copy of which was obtained by The Post.
The meeting indicates the FTC is interested in coming up with a solution instead of simply suing to stop the two biggest office supply retailers from merging, BofA wrote in the report, which was sent to its clients.
“Our conversation was with an industry consultant who is following the merger,” BoA said in the report.
On Oct. 14, The Post reported that Staples had met with regulators to discuss possible remedies to salvage its controversial merger with rival Office Depot.
Up until the meeting, Staples had not been willing to sell assets to gain regulatory clearance.
Critics have railed against the merger, announced in February, claiming it would result in higher office supply prices, especially for national corporate customers who need coast-to-coast coverage and can’t turn to regional chains for lower prices.
Full content: New York Post
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas